Subscribe

Subscribe for the Newsletter

Mobile Navigation

Articles
Expert Interviews
Roundtable
Press Releases
Videos
Market Research

Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing

Company Info

OncoResponse

Drug Discovery & Development

Overview

Contributions

Contributors

Contributions

Nice Insight is the market research division of That's Nice LLC, the leading marketing agency serving life sciences.

Explore

About Us Nice Insight That's Nice

Reach Our Team

Contact Us Advertise LinkedIn

My Account

Subscribe for the newsletter

© 2026 PHARMA'S ALMANAC. All rights reserved.

Privacy Policy Terms And Conditions

0 Contributors1 / 0

No authors found

1 / 0

1 Contributions1 / 1

Clinical Trials

OncoResponse to Present Phase 1 Results of Clinical Study of OR502, anti-LILRB2 Antibody, as a Late-Breaker Poster

OncoResponse

PR-10-24-NI-73Nov 5, 2024

1 / 1